Insulin-like growth factor (IGF)-I and IGF-binding protein-3 serum levels in relapsing-remitting and secondary progressive multiple sclerosis patients (204 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2011 Dec; 18(12): 1402-1406.
Tipo di articolo: Journal Article, Comparative Study, Research Support, Non-U. S. Gov'T,
Impact factor: 3.692, Impact factor a 5 anni: 3.239
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-81855194365&partnerID=40&md5=892560fddc9309053bc0579b51fc2a3d
Parole chiave: Case-Control Study, Insulin-Like Growth Factor-Binding Protein-3, Multiple Sclerosis, Relapsing-Remitting, Secondary Progressive, Somatomedin Binding Protein 3, Adult, Article, Clinical Assessment Tool, Controlled Study, Disease Activity, Disease Course, Expanded Disability Status Scale, Female, Human, Major Clinical Study, Multiple Sclerosis Severity Scale, Priority Journal, Protein Blood Level, Secondary Progressive Multiple Sclerosis, Age Factors, Case-Control Studies, Insulin-Like Growth Factor Binding Protein 3, Middle Aged, Chronic Progressive, Severity Of Illness Index, Time Factors, Insulin-Like Growth Factor Binding Protein 3 Blood Physiology, Insulin-Like Growth Factor I Analysis Physiology, Chronic Progressive Blood Physiopathology, Relapsing-Remitting Blood Physiopathology,
Affiliazioni:
*** IBB - CNR ***
Neurology, Hermitage Capodimonte Hospital, Naples, Italy
Department of Neurological Sciences, University 'Federico II', Naples, Italy
SDN Foundation, Naples, Italy
Biostructure and Bioimaging Institute, National Research Council, Naples, Italy
Department of Health Science, University of Molise, Contrada Tappino, Campobasso, Italy
Departments of Molecular and Clinical Endocrinology and Oncology, University 'Federico II', Naples, Italy
Riferimenti:
Roth, G.A., Spada, V., Hamill, K., Bornstein, M.B., Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue (1995) Brain Res Dev Brain Res, 88, pp. 102-10
Mc Morris, F.A., Smith, T.M., De Salvo, S., Furlanetto, R.W., Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development (1986) Proc Natl Acad Sci U S A, 83, pp. 822-826
Mason, J.L., Ye, P., Suzuki, K., D' Ercole, A.J., Matsushima, G.K., Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination (2000) J Neurosci, 20, pp. 5703-5708
Barres, B.A., Hart, I.K., Coles, H.S., Cell death in the oligodendrocyte lineage (1992) J Neurobiol, 23, pp. 1221-1230
Wilczak, N., Schaaf, M., Bredewold, R., Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis (1998) Neurosci Lett, 257, pp. 168-170
Torres-Aleman, I., Barrios, V., Berciano, J., The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis (1998) Neurology, 50, pp. 772-776
Wilczak, N., Ramsaransing, G.S., Mostert, J., Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis (2005) Mult Scler, 11, pp. 13-15
Poljakovic, Z., Zurak, N., Brinar, V., Growth hormone and insulin growth factor-I levels in plasma and cerebrospinal fluid of patients with multiple sclerosis (2006) Clin Neurol Neurosurg, 108, pp. 255-258
Hosback, S., Hardiman, O., Nolan, C.M., Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis (2007) Growth Horm IGF Res, 17, pp. 472-479
Poser, C.M., Paty, D.W., Scheinberg, L., New diagnostic criteria for multiple sclerosis: guidelines for research protocols (1983) Ann Neurol, 13, pp. 227-231
Oscarsson, J., Johannsson, G., Johansson, J.O., Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults (1997) Clin Endocrinol (Oxf), 46, pp. 63-68
Sonntag, W.E., Ramsey, M., Carter, C.S., Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging (2005) Ageing Res Rev, 4, pp. 195-212
Rensink, A.A., Gellekink, H., Otte-Höller, I., Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease (2002) Acta Neuropathol, 104, pp. 525-533
Lovett-Racke, A.E., Bittner, P., Cross, A.H., Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1)and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3) (1998) J Clin Invest, 101, pp. 1797-1804
Rudick, R., Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis? (2003) Mult Scler, 9, pp. 210-212
Yateman, M.E., Claffey, D.C., Cwyfan Hughes, S.C., Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production (1993) J Endocrinol, 137, pp. 151-159
Besset, V., Le Magueresse-Battistoni, B., Collette, J., Benahmed, M., Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells (1996) Endocrinology, 137, pp. 296-303
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2011 Dec; 18(12): 1402-1406.
Tipo di articolo: Journal Article, Comparative Study, Research Support, Non-U. S. Gov'T,
Impact factor: 3.692, Impact factor a 5 anni: 3.239
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-81855194365&partnerID=40&md5=892560fddc9309053bc0579b51fc2a3d
Parole chiave: Case-Control Study, Insulin-Like Growth Factor-Binding Protein-3, Multiple Sclerosis, Relapsing-Remitting, Secondary Progressive, Somatomedin Binding Protein 3, Adult, Article, Clinical Assessment Tool, Controlled Study, Disease Activity, Disease Course, Expanded Disability Status Scale, Female, Human, Major Clinical Study, Multiple Sclerosis Severity Scale, Priority Journal, Protein Blood Level, Secondary Progressive Multiple Sclerosis, Age Factors, Case-Control Studies, Insulin-Like Growth Factor Binding Protein 3, Middle Aged, Chronic Progressive, Severity Of Illness Index, Time Factors, Insulin-Like Growth Factor Binding Protein 3 Blood Physiology, Insulin-Like Growth Factor I Analysis Physiology, Chronic Progressive Blood Physiopathology, Relapsing-Remitting Blood Physiopathology,
Affiliazioni:
*** IBB - CNR ***
Neurology, Hermitage Capodimonte Hospital, Naples, Italy
Department of Neurological Sciences, University 'Federico II', Naples, Italy
SDN Foundation, Naples, Italy
Biostructure and Bioimaging Institute, National Research Council, Naples, Italy
Department of Health Science, University of Molise, Contrada Tappino, Campobasso, Italy
Departments of Molecular and Clinical Endocrinology and Oncology, University 'Federico II', Naples, Italy
Riferimenti:
Roth, G.A., Spada, V., Hamill, K., Bornstein, M.B., Insulin-like growth factor I increases myelination and inhibits demyelination in cultured organotypic nerve tissue (1995) Brain Res Dev Brain Res, 88, pp. 102-10
Mc Morris, F.A., Smith, T.M., De Salvo, S., Furlanetto, R.W., Insulin-like growth factor I/somatomedin C: a potent inducer of oligodendrocyte development (1986) Proc Natl Acad Sci U S A, 83, pp. 822-826
Mason, J.L., Ye, P., Suzuki, K., D' Ercole, A.J., Matsushima, G.K., Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination (2000) J Neurosci, 20, pp. 5703-5708
Barres, B.A., Hart, I.K., Coles, H.S., Cell death in the oligodendrocyte lineage (1992) J Neurobiol, 23, pp. 1221-1230
Wilczak, N., Schaaf, M., Bredewold, R., Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis (1998) Neurosci Lett, 257, pp. 168-170
Torres-Aleman, I., Barrios, V., Berciano, J., The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis (1998) Neurology, 50, pp. 772-776
Wilczak, N., Ramsaransing, G.S., Mostert, J., Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and primary progressive multiple sclerosis (2005) Mult Scler, 11, pp. 13-15
Poljakovic, Z., Zurak, N., Brinar, V., Growth hormone and insulin growth factor-I levels in plasma and cerebrospinal fluid of patients with multiple sclerosis (2006) Clin Neurol Neurosurg, 108, pp. 255-258
Hosback, S., Hardiman, O., Nolan, C.M., Circulating insulin-like growth factors and related binding proteins are selectively altered in amyotrophic lateral sclerosis and multiple sclerosis (2007) Growth Horm IGF Res, 17, pp. 472-479
Poser, C.M., Paty, D.W., Scheinberg, L., New diagnostic criteria for multiple sclerosis: guidelines for research protocols (1983) Ann Neurol, 13, pp. 227-231
Oscarsson, J., Johannsson, G., Johansson, J.O., Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults (1997) Clin Endocrinol (Oxf), 46, pp. 63-68
Sonntag, W.E., Ramsey, M., Carter, C.S., Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging (2005) Ageing Res Rev, 4, pp. 195-212
Rensink, A.A., Gellekink, H., Otte-Höller, I., Expression of the cytokine leukemia inhibitory factor and pro-apoptotic insulin-like growth factor binding protein-3 in Alzheimer's disease (2002) Acta Neuropathol, 104, pp. 525-533
Lovett-Racke, A.E., Bittner, P., Cross, A.H., Regulation of experimental autoimmune encephalomyelitis with insulin-like growth factor (IGF-1)and IGF-1/IGF-binding protein-3 complex (IGF-1/IGFBP3) (1998) J Clin Invest, 101, pp. 1797-1804
Rudick, R., Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis? (2003) Mult Scler, 9, pp. 210-212
Yateman, M.E., Claffey, D.C., Cwyfan Hughes, S.C., Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production (1993) J Endocrinol, 137, pp. 151-159
Besset, V., Le Magueresse-Battistoni, B., Collette, J., Benahmed, M., Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells (1996) Endocrinology, 137, pp. 296-303
Background: Insulin-like growth factor (IGF)-I has a role in remyelination, and insulin-like growth factor-binding protein-3 (IGFBP-3) might reduce its bioavailability. A role of IGFBP-3 in multiple sclerosis (MS) progression was hypothesized in patients with primary progressive (PP) MS. Objective: To evaluate serum levels of IGF-I and IGFBP-3 in patients with relapsing-remitting (RR) and secondary progressive (SP) MS and their correlations with disease activity and progression. Methods: Sixty-three (41 RR and 22 SP) 'naive' MS patients and 60 age-matched healthy controls were enrolled. Patients were assessed through clinical [Expanded Disability Status Scale (EDSS), Multiple Sclerosis Severity Scale (MSSS), number of relapses] and laboratory investigations. IGF-I and IGFBP-3 were measured by ELISA. Results: Levels of IGF-I and IGFBP-3 were similar in the two MS groups. IGFBP-3 levels were higher in patients with MS than in controls (P<0.001), with a reduction in IGF-I/BP3 ratio (P<0.001). Patients showing IGFBP-3 levels higher than 2SD of the normal population had a higher EDSS (mean EDSS 3.7 vs. 2.8, P=0.021). MSSS was not related to IGF-I or IGFBP-3 serum levels. Conclusions: Our patients showed high IGFBP-3 serum levels respect to controls and higher serum levels were associated with a higher EDSS, despite of comparable disease duration. Therefore, MS and higher disability seem to be associated with a reduction in bioavailability of IGF-I. MSSS score was not related to IGFBP-3 levels, suggesting that IGFBP-3 might not have the pathogenetic role previously suggested for PP MS, in the mechanism of progression in the SP form of disease. © 2011 The Author(s). European Journal of Neurology © 2011 EFNS.
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Coda AR, Anzilotti S, Boscia F, Greco A, Panico M, Gargiulo S, Gramanzini M, Zannetti A, Albanese S, Pignataro G, Annunziato L, Salvatore M, Brunetti A, De Berardinis P, Quarantelli M, Palma G, Pappata S
* In vivo imaging of CNS microglial activation/macrophage infiltration with combined [(18)F]DPA-714-PET and SPIO-MRI in a mouse model of relapsing remitting experimental autoimmune encephalomyelitis (29 visite) (PDF 9 visite)
Eur J Nucl Med Mol Imaging (ISSN: 1619-7070linking), 2020 May 7; N/D: N/D-N/D.
Impact Factor: 7.18
Dettagli Esporta in BibTeX Esporta in EndNote
Pontillo G, Cocozza S, Di Stasi M, Carotenuto A, Paolella C, Cipullo MB, Perillo T, Vola EA, Russo C, Masullo M, Moccia M, Lanzillo R, Tedeschi E, Elefante A, Brescia Morra V, Brunetti A, Quarantelli M, Petracca M
* 2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis (37 visite)
Eur Radiol (ISSN: 0938-7994linking), 2020 Feb 25; N/D: N/D-N/D.
Impact Factor:
Dettagli Esporta in BibTeX Esporta in EndNote
Cassiano MT, Lanzillo R, Alfano B, Costabile T, Comerci M, Prinster A, Moccia M, Megna R, Morra VB, Quarantelli M, Brunetti A
* Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis (47 visite)
Neuroimage Clin (ISSN: 2213-1582linking, 2213-1582electronic), 2020 Jan 30; 26: 102201-102201.
Impact Factor: 2.526
Dettagli Esporta in BibTeX Esporta in EndNote
Gandhi S, Marr K, Mancini M, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Hojnacki D, Kolb C, Weinstock-guttman B, Zivadinov R
* No association between variations in extracranial venous anatomy and clinical outcomes in multiple sclerosis patients over 5 years (98 visite)
Bmc Neurol (ISSN: 1471-2377linking, 1471-2377electronic), 2019 Jun 11; 19(1): 121-121.
Impact Factor: 2.17
Dettagli Esporta in BibTeX Esporta in EndNote
Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M
* Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment (168 visite)
J Neurol (ISSN: 1432-1459electronic, 0340-5354linking, 0340-5354print), 2019 Feb; 266(2): 361-368.
Impact Factor: 3.853
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Pontillo G, Lanzillo R, Russo C, Petracca M, Di Stasi M, Paolella C, Vola EA, Criscuolo C, Moccia M, Lamberti A, Monti S, Brescia Morra V, Elefante A, Palma G, Tedeschi E, Brunetti A
* MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis (210 visite)
Neuroradiology (ISSN: 0028-3940linking, 1432-1920electronic), 2019 Feb; 61(2): 155-162.
Impact Factor: 1.287
Dettagli Esporta in BibTeX Esporta in EndNote
Pontillo G, Cocozza S, Lanzillo R, Russo C, Stasi MD, Paolella C, Vola EA, Criscuolo C, Borrelli P, Palma G, Tedeschi E, Morra VB, Elefante A, Brunetti A
* Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study (117 visite)
Am J Neuroradiol (ISSN: 0195-6108linking, 1936-959xelectronic), 2019 Jan; 40(1): 99-106.
Impact Factor: 3.55
Dettagli Esporta in BibTeX Esporta in EndNote
Arotenuto A, Cocozza S, Quarantelli M, Arcara G, Lanzillo R, Brescia Morra V, Cerillo I, Tedeschi E, Orefice G, Bambini V, Brunetti A, Iodice R
* Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction (244 visite)
Brain Lang (ISSN: 0093-934xlinking), 2018 Oct; 185: 47-53.
Impact Factor: 2.851
Dettagli Esporta in BibTeX Esporta in EndNote
Ugga L, Romeo V, Tedeschi E, Brunetti A, Quarantelli M
* Superparamagnetic iron oxide nanocolloids in MRI studies of neuroinflammation (180 visite)
J Neurosci Methods (ISSN: 0165-0270linking, 1872-678xelectronic), 2018 Jun 18; 310: 12-23.
Impact Factor: 2.668
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Cocozza S, Borrelli P, Ugga L, Morra VB, Palma G
* Longitudinal assessment of dentate nuclei relaxometry during massive gadobutrol exposure (145 visite)
Magn Reson Med Sci (ISSN: 1347-3182), 2018; 17(1): 100-104.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Carbone F, Quarantelli M, Bruzzese D, Carotenuto A, De RosaV, Colamatteo A, Micillo T, De Luca Picione C, Saccà F, De Rosa A, Moccia M, Brescia Morra V, Matarese G
* Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a (187 visite)
Clin Immunol (ISSN: 1521-6616), 2017 Oct; 183: 249-253.
Impact Factor: 3.557
Dettagli Esporta in BibTeX Esporta in EndNote
Jakimovski D, Marr K, Mancini M, Caprio MG, Gandhi S, Bergsland N, Paunkoski I, Hagemeier J, Chandra A, Weinstock-guttman B, Zivadinov R
* Global and regional brain atrophy is associated with low or retrograde facial vein flow in multiple sclerosis (143 visite) (PDF 126 visite)
Veins And Lymphatics, 2017 Sep; 6: N/D-N/D.
Impact Factor: 1.143
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Marr K, Gandhi S, Jakimovski D, Hagemeier J, Weinstock-guttman B, Zivadinov R, Mancini M
* Centralized and local color Doppler ultrasound reading agreement for diagnosis of the chronic cerebrospinal venous insufficiency in patients with Multiple Sclerosis (160 visite)
Curr Neurovasc Res (ISSN: 1567-2026), 2017 Jul 17; N/D: N/D-N/D.
Impact Factor: 1.716
Dettagli Esporta in BibTeX Esporta in EndNote
Pontillo G, Cocozza S, Lanzillo R, Borrelli P, De Rosa A, Brescia Morra V, Tedeschi E, Palma G
* Brain Susceptibility Changes in a Patient with Natalizumab-Related Progressive Multifocal Leukoencephalopathy: A Longitudinal Quantitative Susceptibility Mapping and Relaxometry Study (132 visite)
Front Neurol (ISSN: 1664-2295, 1664-2295linking, 1664-2295print), 2017 Jun 19; 8: 294-294.
Impact Factor: 3.508
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Carotenuto A, Pivonello C, Moccia M, Cianflone A, Marsili A, Puorro G, Sacca F, Russo CV, De Luca Picione C, Ausiello F, Colao A, Brescia Morra V
* Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon beta-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis (178 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2017 Feb; 24(2): 446-449.
Impact Factor: 4.621
Dettagli Esporta in BibTeX Esporta in EndNote
Moccia M, Quarantelli M, Lanzillo R, Cocozza S, Carotenuto A, Carotenuto B, Alfano B, Prinster A, Triassi M, Nardone A, Palladino R, Brunetti A, Brescia Morra V
* Grey: white matter ratio at diagnosis and the risk of 10-year multiple sclerosis progression (224 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2017 Jan; 24(1): 195-204.
Impact Factor: 4.621
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Mancini M
* Vascular Disease in Multiple Sclerosis: A Real Thing? (155 visite) (PDF 152 visite)
Blood Disorders & Transfusion, 2016 Oct; 7: N/D-N/D.
Impact Factor: 0.486
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Pozzilli C, Trojano M, Amato MP, Marrosu MG, Francia A, Florio C, Orefice G, Tedeschi G, Bellantonio P, Annunziata P, Grimaldi LM, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Brescia Morra V
* No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon beta1a therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) (349 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970), 2016 Aug; 22(9): 1163-1173.
Impact Factor: 4.84
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Canna A, Lanzillo R, Russo C, Postiglione E, Liuzzi R, Vastola M, Brunetti A, Salvatore M, Brescia Morra V, Palma G, Tedeschi E
* Lack of correlation between extracranial venous abnormalities and multiple sclerosis: a quantitative MRI study (208 visite)
The British Institute Of Radiology, 2016 Jun; N/D: N/D-N/D.
Impact Factor: 1.84
Dettagli Esporta in BibTeX Esporta in EndNote
Criscuolo C, Lanzillo R, Cianflone A, Liuzzi R, Mancini M, Tedeschi E, Postiglione E, Vacca G, Vacchiano V, Moccia M, Puorro G, Marsili A, Incoronato M, Salvatore M, Brescia Morra V
* Endothelin-1 as a candidate cerebrovascular biomarker in Multiple Scelrosis (172 visite) (PDF 158 visite)
Ectrims - Poster, 2016 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Gandhi S, Mancini M, Marr K, Caprio MG, Jakimovski D, Chandra A, Hagemeier J, Weinstock-guttman B, Zivadinov R
* No association of extra-cranial neous abnormalities and clinical outcomes in multiple sclerosis patients over 5 years (180 visite)
6th Annual Meeting Of The International Society For Neurovascular Disease, 2016 Apr; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Palma G, Canna A, Cocozza S, Russo C, Borrelli P, Lanzillo R, Angelini V, Postiglione E, Morra VB, Salvatore M, Brunetti A, Quarantelli M
* In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents (239 visite)
Eur Radiol (ISSN: 0938-7994, 1432-1084electronic), 2016 Feb 23; 26(12): 4577-4584.
Impact Factor: 3.967
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Chiodi A, Carotenuto A, Magri V, Napolitano A, Liuzzi R, Costabile T, Rainone N, Freda MF, Valerio P, Brescia Morra V
* Quality of life and cognitive functions in early onset multiple sclerosis (275 visite)
Eur J Paediatr Neuro (ISSN: 1090-3798, 1532-2130), 2016 Jan; 20(1): 158-163.
Impact Factor: 2.013
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Russo C, Giugliano A, Ragucci M, Mancini M
* Vascular Disease in Patients with Multiple Sclerosis: A Review (264 visite) (PDF 151 visite)
J Vasc Med Surg, 2016; 4: 1-12.
Impact Factor: 0.163
Dettagli Esporta in BibTeX Esporta in EndNote
Palma G, Tedeschi E, Borrelli P, Cocozza S, Russo C, Liu S, Ye Y, Comerci M, Alfano B, Salvatore M, Haacke EM, Mancini M
* A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain (479 visite) (PDF 226 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015 Aug 18; 10(8): e0134963-e0134963.
Impact Factor: 3.057
Dettagli Esporta in BibTeX Esporta in EndNote
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-kingshott CA, Tozer DJ, Macmanus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT
* Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study (143 visite)
Neurology (ISSN: 0028-3878linking, 1526-632x), 2015 Mar 17; 84 (11 ): 1145-1152.
Impact Factor: 5.065
Dettagli Esporta in BibTeX Esporta in EndNote
Postiglione E, Criscuolo C, Cianflone A, Lanzillo R, Mancini M, Tedeschi E, Liuzzi R, Vacca G, Vastola M, Capasso M, Mancino T, Mormile R, Passannanti A, Palma G, Caprio M, Incoronato M, Salvatore M, Brescia-Morra V
* AN INTERIM ANALYSIS ON SUSCEPTIBILITY TO VASCULAR ALTERATIONS IN MS AND ALS (239 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 21-22.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Canna A, Palma G, Tedeschi E, Cocozza S, Lanzillo R, Russo C, Borrelli P, Postiglione E, Liuzzi R, Criscuolo C, Brescia-Morra V, Mancini M, Salvatore M
* ASSESSING THE CORRELATION BETWEEN IRON DEPOSIT IN THE BASAL GANGLIA AND FLOW ABNORMALITIES IN THE NECK VEINS WITH MRI: PRELIMINARY EXPERIENCE (210 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 20-21.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cervo A, Caprio MG, Ragucci M, Mancini M
* CEREBRAL CIRCULATION IN PATIENTS WITH MULTIPLE SCLEROSIS. A COLOR-DOPPLER STUDY OF EXTRACRANIAL ARTERIAL AND VENOUS VESSELS (196 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 12-12.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cocozza S, Canna A, Lanzillo R, Palma G, Postiglione E, Russo C, Borrelli P, Brescia Morra V, Brunetti A, Salvatore M, Tedeschi E
* Correlation between Neck Venous Drainage and Multiple Sclerosis (188 visite)
Rsna 101st Scientific Assembly And Annual Meeting, 2015; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Cianflone A, Criscuolo C, Lanzillo R, Liuzzi R, Mancini M, Tedeschi E, Postiglione E, Vacca G, Vacchiano V, Moccia M, VastoLa M, Puorro G, Marsili A, Incoronato M, Salvatore M, Brescia-Morra V
* INCREASED ENDOTHELIN-1 SERUM LEVELS IN PATIENTS WITH MULTIPLE SCLEROSIS (308 visite)
Veins And Lymphatics (ISSN: 2279-7483), 2015; 4(s1): 22-22.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Patti F, De Stefano M, Lavorgna L, Messina S, Chisari CG, Ippolito D, Lanzillo R, Vacchiano V, Realmuto S, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Montella P, Morra VB, Savettieri G, Alfano B, Gallo A, Simone I, Viterbo R, Zappia M, Bonavita S, Tedeschi G
* Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients (307 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2015; 10(3): N/D-N/D.
Impact Factor: 3.057
Dettagli Esporta in BibTeX Esporta in EndNote
Criscuolo C, Carbone R, Lieto M, Peluso S, Guacci A, Filla A, Quarantelli M, Lanzillo R, Brescia Morra V, De Michele G
* SPG5 and multiple sclerosis: Clinical and genetic overlap? (243 visite)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2015; 133(6): 410-414.
Impact Factor: 2.559
Dettagli Esporta in BibTeX Esporta in EndNote
Moccia M, Erro R, Montella S, Carotenuto A, Pappata S, Orefice G
* Diagnostic challenges of Parkinsonism occurring in multiple sclerosis (167 visite)
Acta Neurol Belg (ISSN: 0300-9009), 2014 Oct 12; 115(3): 513-515.
Impact Factor: 0.894
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Liuzzi R, Vallefuoco L, Moccia M, Amato L, Vacca G, Vacchiano V, Portella G, Brescia Morra V
* JC virus antibody index in natalizumab-treated patients: correlations with John Cunningham virus DNA and C-reactive protein level (208 visite)
Ther Clin Risk Manag (ISSN: 1178-203x), 2014 Oct 9; 10: 807-814.
Impact Factor: 1.469
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Veria V, Orefice G, Marrosu MG, Trojano M, Amato MP, Francia AM, Florio C, Tedeschi G, Bellantonio P, Annunziata P, Comerci M, Brunetti A, Bonavita V, Alfano B, Marini S, Pozzilli C, Morra VB
* Brain atrophy in relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study) (280 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic), 2014 May; 21(S.I.Suppl.1): 58-58.
Impact Factor: 4.055
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi E, Lanzillo R, Mancini M, Russo C, Cianflone A, Liuzzi R, Cocozza S, Postiglione E, Palma G, Caprio MG, Incoronato MR, Criscuolo C, Brescia Morra V, Salvatore M
* Imaging Of Brain Perfusion In Multiple Sclerosis And Neurodegenerative Diseases: Association With Endothelial Factors. An Interim Analysis (242 visite) (PDF 178 visite)
2014 Joint Actrims-Ectrims Meeting, 2014 Apr 28; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Lanzillo R, Liuzzi R, Di Donato O, Ragucci M, Monti S, Salvatore E, Morra VB, Salvatore M
* Internal jugular vein blood flow in multiple sclerosis patients and matched controls (247 visite) (PDF 170 visite)
Plosone (ISSN: 1932-6203, 1932-6203electronic), 2014 Mar 27; 9(3): e92730-e92730.
Impact Factor: 3.234
Dettagli Esporta in BibTeX Esporta in EndNote
Lavorgna L, Bonavita S, Ippolito D, Lanzillo R, Salemi G, Patti F, Valentino P, Coniglio G, Buccafusca M, Paolicelli D, D'Ambrosio A, Bresciamorra V, Savettieri G, Zappia M, Alfano B, Gallo A, Simone I, Tedeschi G
* Clinical And Magnetic Resonance Imaging Predictors Of Disease Progression In Multiple Sclerosis: A Nine-Year Follow-Up Study (359 visite) (PDF 203 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970), 2014 Feb; 20(2): 220-226.
Impact Factor: 4.822
Dettagli Esporta in BibTeX Esporta in EndNote
Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M
* Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS (299 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 0028-3878linking), 2014 Jan 7; 82(1): 41-48.
Impact Factor: 8.185
Dettagli Esporta in BibTeX Esporta in EndNote
Clerico M, De Mercanti S, Versino E, Piazza F, Gned D, Brescia Morra V, Lanzillo R, Amato L, Quarantelli M, Ghezzi A, Bianchi A, Baroncini D, Salemi G, Realmuto S, Ferro MT, Vitetta F, Donghia M, Paolicelli D, Trojano M, Durelli L
* Management of multiple sclerosis patients after the 24th Natalizumab course: the Ty-STOP study (203 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2013 Oct; 19(11): N/D-N/D.
Impact Factor: 4.863
Dettagli Esporta in BibTeX Esporta in EndNote
Comi G, Battaglia MA, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani MP, Tesio L, Stolz E, Zaratin P, Mancardi G, Mancini M
* Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study (170 visite)
Mult Scler (ISSN: 1477-0970, 1352-4585, 1352-4585linking), 2013 Oct; 19(11): 1508-1517.
Impact Factor: 4.863
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Bonavita S, Quarantelli M, Vacca G, Lus G, Amato L, Carotenuto A, Tedeschi G, Orefice G, Brescia Morra V
* Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice (204 visite)
Neurol Sci (ISSN: 1590-1874, 1590-0187, 1590-3478), 2013 Apr; 34(4): 521-528.
Impact Factor: 0.38
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Mancini M, Liuzzi R, Di Donato O, Salvatore E, Maglio V, Vacca G, Amato L, D'Anna G, Brunetti A, Brescia Morra V
* Chronic cerebrospinal venous insufficiency in multiple sclerosis: a highly prevalent age-dependent phenomenon (293 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2013 Feb 13; 13: 20-20.
Impact Factor: 2.486
Dettagli Esporta in BibTeX Esporta in EndNote
Comi G, Battaglia MA, Bertolotto A, Del Sette M, Ghezzi A, Malferrari G, Salvetti M, Sormani MP, Tesio L, Stolz E, Mancardi G, Mancini M
* Italian Multicentre Observational Study Of The Prevalence Of Ccsvi In Multiple Sclerosis (cosmo Study): Rationale, Design, And Methodology (165 visite)
Neurol Sci, 2013 Jan; N/D: N/D-N/D.
Impact Factor: 1.362
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, Prinster A, Orefice G, Tedeschi G, Brescia Morra V
* Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: A head-to-head retrospective study (253 visite)
Acta Neurol Scand (ISSN: 0001-6314, 1600-0404), 2012 Nov; 126(5): 306-314.
Impact Factor: 2.474
Dettagli Esporta in BibTeX Esporta in EndNote
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
* Efficacy, Safety And Tolerability Of Atorvastatin In Patients With Relapsing-Remitting Multiple Sclerosis In Treatment With Interferon-Beta (arianna): A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group-Study, Lyon. France (299 visite)
Proceedings Of The 23rd Ectrims Meeting Lyon France, 2012 Oct 10; AbstractBook: 477-477.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Brescia Morra V, Alfano B, Lanzillo R, Quarantelli M, Comerci M, Marini S, Vacca G, Amato MP, Trojano M, Brunetti A, Pozzilli C
* Efficacy, safety and tolerability of Atorvastatin in patients with Relapsing-remitting multiple sclerosis in treAtment with INterferoN-beta (ARIANNA): a multicentre, randomised, double-blind, placebo-controlled, parallel-group-study (279 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2012 Oct; 18: 197-197.
Impact Factor: 4.472
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Morra VB, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Salvatore E, Brunetti A, Iaccarino V, Salvatore M
* Multiple sclerosis: cerebral circulation time (231 visite)
Radiology (ISSN: 1527-1315, 0033-8419, 1527-1315electronic), 2012 Mar; 262(3): 947-955.
Impact Factor: 6.339
Dettagli Esporta in BibTeX Esporta in EndNote
Saccà F, Quarantelli M, Rinaldi C, Tucci T, Piro R, Perrotta G, Carotenuto B, Marsili A, Palma V, De Michele G, Brunetti A, Brescia Morra V, Filla A, Salvatore M
* A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results (280 visite)
J Neurol (ISSN: 1432-1459, 0340-5354, 1432-1459electronic), 2012 Jan; 259(1): 132-138.
Impact Factor: 3.578
Dettagli Esporta in BibTeX Esporta in EndNote
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A
* Dysfunction of TGF-β1 signaling in Alzheimer's disease: Perspectives for neuroprotection (440 visite)
Cell Tissue Res (ISSN: 0302-766x), 2012 Jan; 347(1): 291-301.
Impact Factor: 3.677
Dettagli Esporta in BibTeX Esporta in EndNote
Mancini M, Brescia Morra V, Di Donato O, Maglio V, Lanzillo R, Liuzzi R, Brunetti A, Salvatore M
* Contrast-Enhanced Ultrasound Evaluation Of The Cerebral Circulation Time In Patients With Multiple Sclerosis (178 visite)
J Ultrasound Med, 2012; N/D: 49-49.
Impact Factor: 1.532
Dettagli Esporta in BibTeX Esporta in EndNote
Malferrari G, Del Sette M, Zedde M, Sanguigni S, Carraro C, Baracchini C, Mancini M, Stolz E
* Italian multicenter study on venous hemodynamics in multiple sclerosis: Advanced Sonological Protocol (198 visite)
Perspect Med (ISSN: 2211-968x), 2012; 1-12: 399-403.
Impact Factor: 1.132
Dettagli Esporta in BibTeX Esporta in EndNote
Bastianello S, Romani A, Viselner G, Tibaldi EC, Giugni E, Altieri M, Cecconi P, Mendozzi L, Farina M, Mariani D, Galassi A, Quattrini C, Mancini M, Brescia VM, Lagace A, Mcdonald S, Bono G, Bergamaschi R
* Chronic cerebrospinal venous insufficiency in multiple sclerosis: clinical correlates from a multicentre study (205 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2011 Oct 26; 11: 132-132.
Impact Factor: 2.167
Dettagli Esporta in BibTeX Esporta in EndNote
Bastianello S, Giugni E, Amato MP, Tola MR, Trojano M, Galletti S, Luccichenti G, Quarantelli M, Picconi O, Patti F, COGIMUS
* Changes In Magnetic Resonance Imaging Disease Measures Over 3 Years In Mildly Disabled Patients With Relapsing-Remitting Multiple Sclerosis Receiving Interferon Beta-1a In The Cognitive Impairment In Multiple Sclerosis (cogimus) Study (254 visite) (PDF 183 visite)
Bmc Neurol (ISSN: 1471-2377, 1471-2377linking), 2011 Oct 14; 11: 125-125.
Impact Factor: 2.167
Dettagli Esporta in BibTeX Esporta in EndNote
Calabrese V, Cornelius C, Cuzzocrea S, Iavicoli I, Rizzarelli E, Calabrese EJ
* Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity (420 visite)
Molecular Aspects Of Medicine (ISSN: 1872-9452, 0098-2997), 2011 Sep; 32(4-6): 279-304.
Impact Factor: 9.97
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Comerci M, Larobina M, Prinster A, Hornak JP, Selvan SE, Amato U, Quarantelli M, Tedeschi G, Brunetti A, Salvatore M
* An MRI digital brain phantom for validation of segmentation methods (362 visite) (PDF 610 visite)
Med Image Anal (ISSN: 1361-8415, 1361-8423, 1361-8415linking), 2011 Jun; 15(3): 329-339.
Impact Factor: 4.424
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Orefice G, Prinster A, Ventrella G, Liuzzi R, Scarano V, Florio C, Vacca G, Brunetti A, Alfano B, Brescia Morra V, Bonavita V
* Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy (186 visite) (PDF 173 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Apr; 32(2): 287-292.
Impact Factor: 1.315
Dettagli Esporta in BibTeX Esporta in EndNote
Dinacci D, Tessitore A, Russo AA, De Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, Marcuccio L, Comerci M, Galletti P, Alfano B, Tedeschi G
* BDNF Val66Met polymorphism and brain volumes in multiple sclerosis (276 visite) (PDF 190 visite)
Neurol Sci (ISSN: 1590-1874, 1590-3478, 1590-1874linking), 2011 Feb; 32(1): 117-123.
Impact Factor: 1.315
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Ventrella G, Vacca G, Liuzzi R, Amato L, Orefice G, Colao A, Brescia Morra V
* Growth Hormone Axis In Early Multiple Sclerosis Patients Before And After 2 Years Treatment With Interferon Beta-1b - An Interim Analysis (183 visite)
Proceedings Of The Xlii Meeting Of The Italian Society Of Neurology, 2011; nd: 360-360.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Orefice G, Quarantelli M, Rinaldi C, Prinster A, Ventrella G, Spitaleri D, Lus G, Vacca G, Carotenuto B, Salvatore E, Brunetti A, Tedeschi G, Brescia Morra V
* Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: A longitudinal controlled trial of combination therapy (313 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Apr; 16(4): 450-454.
Impact Factor: 4.23
Dettagli Esporta in BibTeX Esporta in EndNote
Prinster A, Quarantelli M, Lanzillo R, Orefice G, Vacca G, Carotenuto B, Alfano B, Brunetti A, Brescia Morra V, Salvatore M
* A voxel-based morphometry study of disease severity correlates in relapsing- remitting multiple sclerosis (226 visite) (PDF 172 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2010 Jan; 16(1): 45-54.
Impact Factor: 4.23
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma MC, Quarantelli M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao AM, Morra VB
* Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients (178 visite)
Journal Of The Neurological Sciences (ISSN: 0022-510x), 2009 Oct; 285: N/D-N/D.
Impact Factor: 2.324
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Di Somma C, Quarantelli M, Gasperi M, Ventrella G, Prinster A, Vacca G, Orefice G, Colao A, Morra VB
* Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis (240 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Sep; 15(9): 1402-1406.
Impact Factor: 3.279
Dettagli Esporta in BibTeX Esporta in EndNote
Dinacci D, Russo AA, Tessitore A, De Bonis ML, Lavorgna L, Picconi O, Sacco R, Bonavita S, Gallo A, Servillo G, Comerci M, Galletti P, Alfano B, Tedeschi G
* BDNF V4166Met Polymorphism and Brain Volumes in Multiple Sclerosis: A Relationship Still Debated (223 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
Dettagli Esporta in BibTeX Esporta in EndNote
Quarantelli M, Lanzillo R, Prinster A, Mollica C, Orefice G, Brunetti A, Vacca G, Salvatore M, Morra VB
* Relationship between Clinical Aspects in Early Phases of Relapsing-Remitting Multiple Sclerosis and Subsequent Brain Volume Changes (240 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2009 Mar 17; 72(11): N/D-N/D.
Impact Factor: 8.172
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B
* Brain atrophy evolution and lesion load accrual in multiple sclerosis: A 2-year follow-up study (319 visite) (PDF 207 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2009 Feb; 15(2): 204-211.
Impact Factor: 3.279
Dettagli Esporta in BibTeX Esporta in EndNote
Morra VB, Prinster A, Lanzillo R, Quarantelli M, Vacca G, Mollica C, Schiavone V, Brunetti A, Salvatore E, Alfano B, Orefice G
* Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population (249 visite) (PDF 172 visite)
Mult Scler (ISSN: 1352-4585, 1477-0970, 1352-4585linking), 2008 Sep; 14: 45-54.
Impact Factor: 3.312
Dettagli Esporta in BibTeX Esporta in EndNote
Vicidomini C, Comerci M, Salvatore E, Quarantelli M, Varrone A, Evangelista L, Prinster A, Morra VB, Brunetti A, Salvatore M, Alfano B, Pappata S
* Combined Mri And Pet-18fdg Study In Patients With Primary Progressive (pp) And Relapsing Remitting (rr) Multiple Sclerosis (ms) (272 visite)
Abstract Book Of Dimi/Emil Annual Meeting 2008, 2008 Jun 1; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Orefice G, Quarantelli M, Lanzillo R, Brunetti A, Salvatore P, Prinster A, Vacca G, Mollica C, Bonavita V, Morra VB, Prinster A
* An open-label randomised clinical trial of atorvastatin in combination with IFN Beta 1a in active multiple sclerosis patients: preliminary results (233 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2008 Jun; 255: N/D-N/D.
Impact Factor: 2.536
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Dinacci D, Lavorgna L, Prinster A, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Servillo G, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Paolillo A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone I, Salvatore M, Bonavita V, Alfano B
* Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability (332 visite) (PDF 197 visite)
J Neurol Sci (ISSN: 0022-510x), 2007 Dec 15; 263(1-2): 15-19.
Impact Factor: 2.315
Dettagli Esporta in BibTeX Esporta in EndNote
Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM
* Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity (346 visite)
Nature Reviews Neuroscience (ISSN: 1471-0048), 2007 Oct; 8(10): 766-775.
Impact Factor: 24.52
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, De Pietro G, Esposito A
* An ontology approach for classification of abnormal white matter in patients with Multiple Sclerosis (273 visite) (PDF 207 visite)
Lecture Notes In Computer Science (ISSN: 0302-9743, 0302-974335404636319783540463634, 0302-974335402975459783540297543), 2007; 4799LNCS: 389-402.
Impact Factor: 0.302
Dettagli Esporta in BibTeX Esporta in EndNote
Lanzillo R, Prinster A, Scarano V, Liuzzi R, Coppola G, Florio C, Salvatore E, Schiavone V, Brunetti A, Muto M, Orefice G, Alfano B, Bonavita V, Brescia Morra V
* Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b (199 visite) (PDF 171 visite)
J Neurol Sci (ISSN: 0022-510x), 2006 Jun 15; 245(1-2): 141-145.
Impact Factor: 2.412
Dettagli Esporta in BibTeX Esporta in EndNote
Prinster A, Quarantelli M, Orefice G, Lanzillo R, Brunetti A, Mollica C, Salvatore E, Morra VB, Coppola G, Vacca G, Alfano B, Salvatore M
* Grey matter loss in relapsing-remitting multiple sclerosis: A voxel-based morphometry study (225 visite) (PDF 182 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2006 Feb 1; 29(3): 859-867.
Impact Factor: 5.559
Dettagli Esporta in BibTeX Esporta in EndNote
Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B
* Brain atrophy and lesion load in a large population of patients with multiple sclerosis (307 visite) (PDF 212 visite)
Neurology (ISSN: 0028-3878, 1526-632x, 1526-632xelectronic), 2005 Jul 26; 65(2): 280-285.
Impact Factor: 5.065
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Di Somma C, Cuocolo A, Filippella M, Rota F, Acampa W, Savastano S, Salvatore M, Lombardi G
* The severity of growth hormone deficiency correlates with the severity of cardiac impairment in 100 adult patients with hypopituitarism: An observational, case-control study (189 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2004 Dec; 89(12): 5998-6004.
Impact Factor: 5.778
Dettagli Esporta in BibTeX Esporta in EndNote
Morra VB, Quarantelli M, Lanzillo R, Prinster A, Coppola G, Brunetti A, Salvatore E, Mollica C, Orefice R, Liuzzi R, Alfano B, Orefice G
* Normal and abnormal brain tissue volumes and neuropsychological status in relapsing-remitting multiple sclerosis (197 visite)
Eur J Neurol (ISSN: 1351-5101, 1468-1331electronic, 1351-5101linking), 2004 Sep; 11: N/D-N/D.
Impact Factor: 2.225
Dettagli Esporta in BibTeX Esporta in EndNote
Morra V, Quarantelli M, Lanzillo R, Prinster A, Coppola G, Brunetti A, Salvatore E, Mollica C, Orefice R, Liuzzi R, Alfano B, Orefice G
* Normal and abnormal brain tissue volumes and neuropsychological status in relapsing-remitting multiple sclerosis (194 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 2004 Jun; 251: N/D-N/D.
Impact Factor: 3.14
Dettagli Esporta in BibTeX Esporta in EndNote
Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A
* Brain tissue volume changes in relapsing-remitting multiple sclerosis: Correlation with lesion load (317 visite) (PDF 196 visite)
Neuroimage (ISSN: 1053-8119, 1053-8119linking), 2003 Feb; 18(2): 360-366.
Impact Factor: 6.192
Dettagli Esporta in BibTeX Esporta in EndNote
Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H
* Diffusion tensor imaging: Concepts and applications (534 visite)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic), 2001 Apr; 13(4): 534-546.
Impact Factor: 2.41
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, Larobina M, Quarantelli M, Tedeschi E, Ciarmiello A, Covelli EM, Salvatore M
Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis (324 visite) (PDF 573 visite)
J Magn Reson Imaging (ISSN: 1053-1807, 1522-2586electronic, 1053-1807linking), 2000 Dec; 12(6): 799-807.
Impact Factor: 1.302
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M
Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation (380 visite) (PDF 550 visite)
Magn Reson Med (ISSN: 0740-3194, 1522-2594electronic), 1998 Mar; 39(3): 497-499.
Impact Factor: 2.962
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Brunetti A, Ciarmiello A, Covelli E, Larobina M, Salvatore M
Automated lesion identification and volumetric measurement of lesion load in multiple sclerosis using a multispectral relaxometric MR approach (177 visite)
Radiology (ISSN: 0033-8419, 1527-1315, 1527-1315electronic), 1997 Nov; 205: N/D-N/D.
Impact Factor: 4.989
Dettagli Esporta in BibTeX Esporta in EndNote
Brunetti A, Tedeschi G, Di Costanzo A, Covelli EM, Aloj L, Bonavita S, Ciarmiello A, Alfano B, Salvatore M
White matter lesion detection in multiple sclerosis: Improved interobserver concordance with multispectral MRI display (247 visite) (PDF 202 visite)
J Neurol (ISSN: 0340-5354, 1432-1459, 1432-1459electronic), 1997 Sep; 244(9): 586-590.
Impact Factor: 1.976
Dettagli Esporta in BibTeX Esporta in EndNote
BRUNETTI A, TEDESCHI G, ALFANO B, DICOSTANZO A, ALOJ L, ARPAIA M, COVELLI E, BONAVITA S, SALVATORE M
Multiparametric characterization of lesions of the white matter in multiple sclerosis patients (189 visite)
Neuroradiology 1994, 1994; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Pozzilli C, Bernardi S, Mansi L, Picozzi P, Iannotti F, Alfano B, Bozzao L, Lenzi GL, Salvatore M, Conforti P
Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography (418 visite) (PDF 202 visite)
J Neurol Neurosurg Psychiatry (ISSN: 0022-3050), 1988 Sep; 51(8): 1058-1062.
Impact Factor: 3.041
Dettagli Esporta in BibTeX Esporta in EndNote
Morbelli S\r -, Esposito G\r -, Arbizu J\r -, Barthel H\r -, Boellaard R\r -, Bohnen Ni\r -, Brooks Dj\r -, Darcourt J\r -, Dickson Jc\r -, Douglas D\r -, Drzezga A\r -, Dubroff J\r -, Ekmekcioglu O\r -, Garibotto V\r -, Herscovitch P\r -, Kuo P\r -, Lammertsma A\r -, Pappata S\r -, Peñuelas I\r -, Seibyl J\r -, Semah F\r -, Tossici-bolt L\r -, Van De Giessen E\r -, Van Laere K\r -, Varrone A\r -, Wanner M\r -, Zubal G\r -, Law I\r -, Iasevoli F\r -, Cocozza S\r -, D’ambrosio L\r -, Ciccarelli M\r -, Barone A\r -, Notar Francesco D\r -, Pontillo G\r -, Brunetti A\r -, Cuocolo A\r -, Pappatà S\r -, De Bartolomeis A\r -, Nappi C\r -, Megna R\r -, Acampa W\r -, Assante R\r -, Zampella E\r -, Gaudieri V\r -, Mannarino T\r -, Green R\r -, Cantoni V\r -, Petretta M\r -, Cuocolo A\r -, Carli E\r -, Caviglia Gp\r -, Pellicano R\r -, Fagoonee S\r -, Rizza S\r -, Astegiano M\r -, Saracco Gm\r -, Ribaldone Dg\r -, Cassiano Mt\r -, Lanzillo R\r -, Alfano B\r -, Costabile T\r -, Comerci M\r -, Prinster A\r -, Moccia
- EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1. 0. - M139. DIFFERENTIAL PATTERNS OF BRAIN METABOLISM IN STABILIZED, ACTIVELY SYMPTOMATIC TREATMENT RESISTANT VS. TREATMENT RESPONDER SCHIZOPHRENIA PATIENTS: A STUDY BY 18F-FDG-POSITRON EMISSION TOMOGRAPHY AND STRUCTURAL 3T MRI. - Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. - Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. - Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis. - Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy. - Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice. - Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Disea (22 visite) (PDF 15 visite)
Hum Brain Mapp 2019 May 08 40 (ISSN: 3631-46doi, 1010-02hbm24621humbrainmapp2018jan09394, 1755-64doi), N/D; (-1619-7070(Print): N/D-N/D.
Impact Factor:
Dettagli Esporta in BibTeX Esporta in EndNote
Nappi C\r -, Megna R\r -, Acampa W\r -, Assante R\r -, Zampella E\r -, Gaudieri V\r -, Mannarino T\r -, Green R\r -, Cantoni V\r -, Petretta M\r -, Cuocolo A\r -, Carli E\r -, Caviglia Gp\r -, Pellicano R\r -, Fagoonee S\r -, Rizza S\r -, Astegiano M\r -, Saracco Gm\r -, Ribaldone Dg\r -, Cassiano Mt\r -, Lanzillo R\r -, Alfano B\r -, Costabile T\r -, Comerci M\r -, Prinster A\r -, Moccia M\r -, Megna R\r -, Morra Vb\r -, Quarantelli M\r -, Brunetti A\r -, Liuzzi R\r -, Piccolo C\r -, D’avino V\r -, Clemente S\r -, Oliviero C\r -, Cella L\r -, Pugliese M\r -, Brunetto Mr\r -, Bertani L\r -, Caviglia Gp\r -, Antonioli L\r -, Pellicano R\r -, Fagoonee S\r -, Astegiano M\r -, Saracco Gm\r -, Bugianesi E\r -, Blandizzi C\r -, Costa F\r -, Ribaldone Dg\r -, Caviglia Gp\r -, Rosso C\r -, Stalla F\r -, Rizzo M\r -, Massano A\r -, Abate Ml\r -, Olivero A\r -, Armandi A\r -, Vanni E\r -, Younes R\r -, Fagoonee S\r -, Pellicano R\r -, Astegiano M\r -, Saracco Gm\r -, Bugianesi E\r -, Ribaldone Dg\r -, Pisconti S\r -
- Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. - Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. - Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis. - Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy. - Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice. - Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. - On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. - Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review. - Human liver stem cells express UGT1A1 and improve ph (9 visite)
Hum Brain Mapp 2019 May 08 40 (ISSN: 3631-46doi, 1010-02hbm24621humbrainmapp2018jan09394, 1755-64doi), N/D; (-1619-7070(Print): N/D-N/D.
Impact Factor:
Dettagli Esporta in BibTeX Esporta in EndNote
Nappi C\r -, Megna R\r -, Acampa W\r -, Assante R\r -, Zampella E\r -, Gaudieri V\r -, Mannarino T\r -, Green R\r -, Cantoni V\r -, Petretta M\r -, Cuocolo A\r -, Carli E\r -, Caviglia Gp\r -, Pellicano R\r -, Fagoonee S\r -, Rizza S\r -, Astegiano M\r -, Saracco Gm\r -, Ribaldone Dg\r -, Cassiano Mt\r -, Lanzillo R\r -, Alfano B\r -, Costabile T\r -, Comerci M\r -, Prinster A\r -, Moccia M\r -, Megna R\r -, Morra Vb\r -, Quarantelli M\r -, Brunetti A\r -, Scarpellini E\r -, Fagoonee S\r -, Rinninella E\r -, Rasetti C\r -, Aquila I\r -, Larussa T\r -, Ricci P\r -, Luzza F\r -, Abenavoli L\r -, Liuzzi R\r -, Piccolo C\r -, D’avino V\r -, Clemente S\r -, Oliviero C\r -, Cella L\r -, Pugliese M\r -, Fagoonee S\r -, Pellicano R\r -, Brunetto Mr\r -, Bertani L\r -, Caviglia Gp\r -, Antonioli L\r -, Pellicano R\r -, Fagoonee S\r -, Astegiano M\r -, Saracco Gm\r -, Bugianesi E\r -, Blandizzi C\r -, Costa F\r -, Ribaldone Dg\r -, Caviglia Gp\r -, Rosso C\r -, Stalla F\r -, Rizzo M\r -, Massano A\r -, Abate Ml\r -
- Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. - Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. - Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis. - Gut Microbiota and Liver Interaction through Immune System Cross-Talk: A Comprehensive Review at the Time of the SARS-CoV-2 Pandemic. - Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy. - Promises of Fibroblast Growth Factor Receptor–Directed Therapy in Tailored Cancer Treatment. - Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice. - Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. - On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic (21 visite)
Int J Mol Sci 2020 Jan 16 21 (ISSN: 1033-90ijms21020575microorganisms2020jan3082, 1033-90microorganisms8020189 cells2020feb0792, 1033-90cells9020386 actamyol2020mar01391), N/D; (-1619-7070(Print): N/D-N/D.
Impact Factor:
Dettagli Esporta in BibTeX Esporta in EndNote
Carli E\\r -, Caviglia Gp\\r -, Pellicano R\\r -, Fagoonee S\\r -, Rizza S\\r -, Astegiano M\\r -, Saracco Gm\\r -, Ribaldone Dg\\r -, Cassiano Mt\\r -, Lanzillo R\\r -, Alfano B\\r -, Costabile T\\r -, Comerci M\\r -, Prinster A\\r -, Moccia M\\r -, Megna R\\r -, Morra Vb\\r -, Quarantelli M\\r -, Brunetti A\\r -, Liuzzi R\\r -, Piccolo C\\r -, D’avino V\\r -, Clemente S\\r -, Oliviero C\\r -, Cella L\\r -, Pugliese M\\r -, Brunetto Mr\\r -, Bertani L\\r -, Caviglia Gp\\r -, Antonioli L\\r -, Pellicano R\\r -, Fagoonee S\\r -, Astegiano M\\r -, Saracco Gm\\r -, Bugianesi E\\r -, Blandizzi C\\r -, Costa F\\r -, Ribaldone Dg\\r -, Caviglia Gp\\r -, Rosso C\\r -, Stalla F\\r -, Rizzo M\\r -, Massano A\\r -, Abate Ml\\r -, Olivero A\\r -, Armandi A\\r -, Vanni E\\r -, Younes R\\r -, Fagoonee S\\r -, Pellicano R\\r -, Astegiano M\\r -, Saracco Gm\\r -, Bugianesi E\\r -, Ribaldone Dg\\r -, Pisconti S\\r -, Della Vittoria Scarpati G\\r -, Buonerba C\\r -, Messinese S\\r -, Carella R\\r -, Di Marzo M\\r -, Di Lor
- Incidence of Prostate Cancer in Inflammatory Bowel Disease: A Meta-Analysis. - Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis. - Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy. - Hepatitis B Virus RNA Detection and a Mindful Use of Serum Hepatitis B Virus DNA and Hepatitis B Surface Antigen Measures in Clinical Practice. - Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. - On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases. - Management of Ewing Sarcoma Family of Tumors: A Short Description of a Rare Primitive Uterine pPNET and Literature Review. - Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I mice. - Facioscapulohumeral muscula (54 visite)
Radiol Case Rep 2018 Dec 05 14 (ISSN: 3091-4doi, 1010-16jradcr201811007ajnramjneuroradiol2019jan401, 9910-6doi), N/D; (-1010-660X(Print): N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
Pota M, Esposito M, Megna R, De Pietro G, Quarantelli M, Brescia Morra V, Alfano B
Multivariate fuzzy analysis of brain tissue volumes and relaxation rates for supporting the diagnosis of relapsing-remitting multiple sclerosis (329 visite)
Biomedical Signal Processing And Control, N/D; 53: N/D-N/D.
Impact Factor: 2.943
Dettagli Esporta in BibTeX Esporta in EndNote
92 Records (67 escludendo Abstract e Conferenze).
Impact factor totale: 270.138 (217.962 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 283.371 (229.22 escludendo Abstract e Conferenze).
Impact factor totale: 270.138 (217.962 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 283.371 (229.22 escludendo Abstract e Conferenze).
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Marco Comerci in data Sunday 12 July 2020, 13:14:58
204 visite. Ultima visita in data Sunday 06 September 2020, 9:20:27
ibb.cnr.it